PBF-680, an oral A1 adenosine receptor antagonist, increases trough forced expiratory volume in 1 second (FEV1) in mild-to-moderate asthma: a Phase-II trial
Year: 2024
Type: conference-abstract
Authors: David Ramos Barbon, Saúl Saldaña Marín, Nadia Sonia Brienza, Rosa Maria Antonijoan Arbos, José Luis Velasco Garrido, Ángel Ferrer Torres, Mariana Muñoz Esquerre, José Gregorio Soto Campos, Carlos Martínez Rivera, Juan Alberto Luna Porta, Santiago Figueroa Pérez, Miriam Soler Palacín, Alina Ariosa Álvarez, Nahomi Castro Palomino Laria, Julio Castro Palomino Laria
Institutions: Universitat Autònoma de Barcelona, Hospital de Sant Pau, Institut de Recerca Sant Pau, Palobiofarma (Spain), Hospital Clínico Universitario Virgen de la Victoria, Hospital Vega Baja, Bellvitge University Hospital, Hospital Universitario de Jerez, Hospital Universitari Germans Trias i Pujol, Hospital Universitario La Paz
Language: English
Subfield: Physiology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4404100103
